RYTM

Rhythm Pharmaceuticals, Inc. Common Stock
Data: 2026-03-31
$86.97
Price
12.58%
Change
$122.2
52W High
$45.905
52W Low

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Quick Stats
Mar 31, 2026

57.1

AI Score

HOLD

2.01

Volume Ratio

May 06, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

RYTM Stock Summary

Last updated Mar 31, 2026

RYTM is currently trading at $86.97, positioned below its 200-day moving average of $96.76, suggesting bearish momentum. The stock has a 52-week range of $45.905 to $122.2.

Technical Analysis: The 50-day moving average stands at $95.84, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 47.517, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.056, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RYTM at 57.1/100 with a HOLD recommendation.

RYTM (Rhythm Pharmaceuticals, Inc. Common Stock) Indicators

Last updated Mar 31, 2026

Indicator Value
RSI(14) 47.517
CMF (20) 0.056
ROC (10) -0.81
ADX (14) 21.715
Indicator Value
MACD (12,26,9) -4.259
AROONOSC (14) -42.857
WILLAMS %R (14) -51.098
MFI (14) 47.078
RYTM Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

RYTM Price vs Max Options Open Interest
RYTM Max Change In Options Open Interest

RYTM Options - Sort by Max open Interest (near term)

1st April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RYTM Daily Out of Money Options - Sort by Max open Interest (near term)

1st April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RYTM Daily In the Money Options - Sort by Max open Interest (near term)

1st April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RYTM Most Active Options by Volume(near term)

1st April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Rhythm Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

RYTM Moving Averages Analysis

RYTM (Rhythm Pharmaceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Mar 31, 2026

Days MA
10 83.74
20 87.31
30 90.66
50 95.84
100 100.61
200 96.76

RYTM Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 5.3 billion
Earnings/Share ($) -3.11
Net Proft Margin (%) -1.0357
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.0735
EPS Estimate Next Year ($) -0.3276
WallStreet Target Price ($) 137.2667
Most Recent Quarter